- Home
- BLZE vs ATAI Comparison
BLZE vs ATAI Comparison
Compare BLZE & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- ATAI
- Stock Information
- Founded
- BLZE 2007
- ATAI 2018
- Country
- BLZE United States
- ATAI Germany
- Employees
- BLZE N/A
- ATAI N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- BLZE Technology
- ATAI Health Care
- Exchange
- BLZE Nasdaq
- ATAI Nasdaq
- Market Cap
- BLZE 252.4M
- ATAI 282.6M
- IPO Year
- BLZE 2021
- ATAI 2021
- Fundamental
- Price
- BLZE $5.73
- ATAI $2.47
- Analyst Decision
- BLZE Strong Buy
- ATAI Strong Buy
- Analyst Count
- BLZE 6
- ATAI 3
- Target Price
- BLZE $10.83
- ATAI $10.50
- AVG Volume (30 Days)
- BLZE 518.4K
- ATAI 2.2M
- Earning Date
- BLZE 05-07-2025
- ATAI 05-14-2025
- Dividend Yield
- BLZE N/A
- ATAI N/A
- EPS Growth
- BLZE N/A
- ATAI N/A
- EPS
- BLZE N/A
- ATAI N/A
- Revenue
- BLZE $132,273,000.00
- ATAI $1,863,000.00
- Revenue This Year
- BLZE $15.55
- ATAI $242.21
- Revenue Next Year
- BLZE $14.48
- ATAI N/A
- P/E Ratio
- BLZE N/A
- ATAI N/A
- Revenue Growth
- BLZE 21.81
- ATAI 572.56
- 52 Week Low
- BLZE $3.94
- ATAI $1.03
- 52 Week High
- BLZE $8.08
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- BLZE 59.80
- ATAI 78.86
- Support Level
- BLZE $5.52
- ATAI $2.18
- Resistance Level
- BLZE $6.05
- ATAI $2.38
- Average True Range (ATR)
- BLZE 0.30
- ATAI 0.19
- MACD
- BLZE 0.03
- ATAI 0.07
- Stochastic Oscillator
- BLZE 54.50
- ATAI 88.09
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.